A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy - Caroline Duineveld; Nicole C.A.J. van de Kar; Jack F.M. Wetzels (Kidney International Reports)